Clinical Trials Browser

Phase 2 × Peripheral Nervous System Diseases × Bortezomib × Clear all

NCT02093910 2014-11-19

Efficacy of Monosialotetrahexosylganglioside in the Prophylactic Treatment of Bortezomib-induced Peripheral Neuropathy

Phase 2 Unknown

Multiple Myeloma, Peripheral Nervous System Diseases